Skip to main content

Big pharma

I got a surprise package from Big Pharma today. Last week I filled my first US prescription for Tagrisso, so AstraZeneca sent me a "starter pack." 


If I didn't have insurance, a month's supply of Tagrisso would cost over $15,000. With Aetna, I'm paying $50. There's plenty to hate about Big Pharma (Exhibit A: Purdue Pharma and Sackler family), but I am thankful for scientific advances that have made targeted cancer therapy possible. I wish these therapies were available for everyone who needs them, not just the insured.  

Comments

  1. AnonymousSeptember 10, 2022 at 12:05 PM

    I wish too. I hate big pharma

    ReplyDelete
  2. KaiSeptember 11, 2022 at 10:10 AM

    But…but…!!! That would be SOCiALISM!!!! On my last trip to PA saw a bumper sticker on a car that said “I’ll fight socialism until hell freezes over. And then I’ll battle on the ice.” Uh huh. I hope you get to feeling better Esther and kick this thing quickly. We are pulling for you.

    ReplyDelete
    Replies
    1. Esther PrinsSeptember 12, 2022 at 10:27 AM

      Thanks, Kai! The cost of US healthcare is insane. :( My 2 weeks in Reston ICU cost $173K+. I've paid about $70 for various items.

      Delete

Post a Comment

Popular posts from this blog

regular update

I had my regular oncology appointment in Pittsburgh yesterday. Dr. Villaruz said the scans look good and everything is stable. Although I don’t have much scanxiety nowadays, it’s always a relief to get good news. Just to be sure that my understanding was correct, I asked her why I’m not a candidate for surgery. It’s because of the cancer’s growth pattern. The one nodule that’s visible on the CT scan could just be scarring; she’s not sure if it’s a tumor. When I was diagnosed, I was told the lung cancer was “lepidic.” This means that the tumor cells were growing along the lining of the alveolar structures (air sacs).* That’s why my lungs looked like they were draped in cobwebs. You can’t do surgery in enough places to get all of it. Thankfully, Tagrisso swept out those cobwebs – and continues to do so. We go back in December for a regular appointment. *Lepidic spread tends to be slow-growing, with minimal invasion of nearby tissues, less chance of metastasis, and overall better progno...
10 comments
Read more

38.6 months

September 18 marked 38.6 months (3 years, 2 months, 18 days) since I first started taking Tagrisso. Why is 38.6 months significant? Because it is the median overall survival in the FLAURA study, a landmark study (2014-16) comparing Tagrisso and older targeted therapies among patients with advanced non-small cell lung cancer, EGFR mutation, and no prior treatment. 279 patients received Tagrisso and 277 people received an older drug (in addition, all patients received at least one dose of a trial drug). Nearly 58% of patients had died when data collection stopped. However, patients in the Tagrisso group lived nearly 7 months longer (median) than the control group. When Leland and I initially read that number – 38.6 months – in the Tagrisso promotional materials, we were stunned. This was supposed to be good news? The median age in the FLAURA study was 64 and at the time (August 2022), I had just turned 50. But still, it was a sobering statistic. For the longest time, I didn't feel ...
14 comments
Read more

A failure of institutional care

I just hit "send" on this letter to my dean and associate dean. Mic drop. I've never sent such a scathing letter, but it's definitely called for in this situation. I'm not expecting anything other than a "Oh, that wasn't how we intended to make you feel; our hands were tied" email. Dear Dean Lawless and Associate Dean Lloyd, When I wrote to Professor Land [my department head] to see if I could get a course release this fall due to having lung cancer plus complications from pulmonary embolism and COVID, I had no idea what I was in for. When faculty friends in other colleges have had health crises (ones that don’t warrant a full-semester medical leave), their department head or dean has simply said, “Don’t worry about teaching this semester. We’ll figure it out.” I figured the same would happen in my case. To be blunt, the way that my case was handled was a colossal failure of leadership. As my husband and I have shared my story with colleagues at PSU ...
26 comments
Read more